Is Wellbutrin an Antidepressant? Yes—Here’s How It Works

Yes, Wellbutrin is an antidepressant. It is FDA-approved for treating major depressive disorder and preventing seasonal affective disorder. But it works differently from the antidepressants most people are familiar with, which is often why the question comes up in the first place.

How Wellbutrin Differs From Other Antidepressants

Most commonly prescribed antidepressants, like SSRIs (Prozac, Zoloft, Lexapro), work primarily by increasing serotonin levels in the brain. Wellbutrin doesn’t do this. Instead, it boosts two other brain chemicals: dopamine and norepinephrine. It has no meaningful effect on serotonin at all. This makes it the only antidepressant in its class, known as a norepinephrine-dopamine reuptake inhibitor (NDRI).

When Wellbutrin first arrived in the U.S. in 1989, it was labeled an “atypical” antidepressant because its effects didn’t match any existing category. Researchers knew it worked differently from older antidepressants like tricyclics and MAOIs, and also differently from SSRIs, but hadn’t yet pinpointed exactly how. Since then, clinical data has confirmed that it blocks the reabsorption of dopamine and norepinephrine, with slightly stronger activity on dopamine. This dopamine involvement is a key reason Wellbutrin can feel noticeably different from serotonin-based medications.

What Wellbutrin Is Approved to Treat

The FDA has approved Wellbutrin for two conditions: major depressive disorder (MDD) and seasonal affective disorder (SAD). These are its on-label uses as an antidepressant.

The same active ingredient, bupropion, is also sold under a different brand name, Zyban, specifically for smoking cessation. Zyban works by reducing nicotine cravings. If you’re prescribed Wellbutrin for depression, you should not also take Zyban, since they contain the same drug. Bupropion is also used off-label for ADHD in adults, particularly when stimulant medications aren’t tolerated or aren’t a good fit. A Cochrane review found that it reduced ADHD symptom severity and increased the proportion of participants who showed clinical improvement, though the evidence quality was rated low.

Why People Choose Wellbutrin Over SSRIs

Two side effects drive many people away from SSRIs: weight gain and sexual dysfunction. Wellbutrin has a notably different profile on both counts.

Across multiple clinical trials, bupropion was associated with modest weight loss rather than gain. In five large placebo-controlled studies totaling nearly 3,000 participants, median weight loss ranged from about 1 to 1.5 kilograms (roughly 2 to 3 pounds) over eight weeks. Placebo groups gained a small amount, and some SSRIs like sertraline showed less weight loss than bupropion. Two longer-term studies following participants for a full year also found significant weight loss with bupropion.

On sexual function, the difference is even clearer. Bupropion caused no more sexual side effects than a placebo in clinical trials. By comparison, up to one in six people taking sertraline experienced orgasm difficulties within the first week. A pooled analysis comparing bupropion to escitalopram (Lexapro) found that orgasm dysfunction and worsened sexual functioning were significantly more common with escitalopram, while bupropion was statistically indistinguishable from placebo. For patients already experiencing sexual side effects from an SSRI, switching to or adding bupropion has been shown to improve sexual function.

How Long It Takes to Work

Like other antidepressants, Wellbutrin doesn’t work overnight. You may notice early changes in sleep, energy, and appetite within the first one to two weeks. These are often the first signs the medication is having an effect. Improvements in mood, motivation, and interest in activities typically take six to eight weeks to develop, and it can be a few months before the full benefit is clear. This timeline is roughly in line with SSRIs, so patience during the early weeks is important.

Available Forms and Dosing

Wellbutrin comes in three formulations: immediate-release (IR), sustained-release (SR), and extended-release (XL). The difference is how quickly the drug enters your system and how often you take it. IR tablets are taken two to three times daily, SR tablets twice daily, and XL tablets once daily in the morning. Most people start at 150 mg per day, with the dose adjusted over time based on response.

The maximum recommended dose is 450 mg per day. This ceiling exists because seizure risk climbs sharply above it. Between 450 and 600 mg per day, the estimated seizure incidence increases nearly tenfold. Staying within the recommended range keeps this risk very low, but it’s the primary reason doses are carefully capped.

Common Side Effects

Because Wellbutrin increases dopamine and norepinephrine rather than serotonin, its side effect profile feels different from SSRIs. The most commonly reported effects include dry mouth, insomnia, headache, nausea, and agitation. Some people describe feeling more “activated” or energized, which can be helpful for depression that involves fatigue and low motivation but less ideal for people who already feel anxious or restless.

Insomnia is one of the more common complaints, which is why the XL formulation is typically taken in the morning. Taking it later in the day can make sleep problems worse. The activating quality of Wellbutrin is a double-edged feature: it’s often the reason people prefer it over sedating antidepressants, but it can also feel like too much stimulation for some.